Document is current
Any future updates will be listed below
-
Authors
Yu, Jun
Kumar, Amit
Zhang, Xuefeng https://orcid.org/0000-0002-5222-7042
Martin, Charlotte
Van holsbeeck, Kevin https://orcid.org/0000-0002-9345-4962
Raia, Pierre https://orcid.org/0000-0003-3469-1922
Koehl, Antoine
Laeremans, Toon
Steyaert, Jan https://orcid.org/0000-0002-3825-874X
Manglik, Aashish https://orcid.org/0000-0002-7173-3741
Ballet, Steven https://orcid.org/0000-0003-4123-1641
Boland, Andreas https://orcid.org/0000-0003-1218-6714
Stoeber, Miriam https://orcid.org/0000-0002-5210-2864
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (TMSGI3_211581, PCEFP3_181282)
European Molecular Biology Organization
Helmut Horten foundation
Vrije Universiteit Brussel (Strategic Research Program (SRP50))
Boninchi Foundation
- License Information
-
More Information
Article History
Received: 16 December 2023
Accepted: 24 September 2024
First Online: 9 October 2024
Competing interests
: M.S., A.B., S.B., A.K., J.Y., K.V.h. and C.M. have filed a priority patent application around the new cyclic peptides targeting the µOR on Sep 12, 2024, with filing number EP24200109.7. The remaining authors declare no other competing interests.
